Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 70422 [2023-22490]

Download as PDF 70422 Federal Register / Vol. 88, No. 195 / Wednesday, October 11, 2023 / Notices FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than November 13, 2023. A. Federal Reserve Bank of Dallas (Karen Smith, Director, Mergers & Acquisitions) 2200 North Pearl Street, Dallas, Texas 75201–2272. Comments can also be sent electronically to Comments.applications@dal.frb.org: 1. Unifi Financial, Inc., San Antonio, Texas; to become a bank holding company by acquiring Stockmens National Bank in Cotulla, Cotulla, Texas. Board of Governors of the Federal Reserve System. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2023–22490 Filed 10–10–23; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA–2013–N–0804; FDA– 2010–N–0598; FDA–2022–N–0081; FDA– 2022–N–1886; FDA–2022–N–2657; FDA– 2023–N–0895; FDA–2023–N–0343; FDA– 2023–N–0134; FDA–2022–N–3208; FDA– 2017–N–0084; FDA–2023–N–1168; FDA– 2016–N–2474; FDA–2014–N–0086; FDA– 2017–N–0366; FDA–2019–N–3657; FDA– 2023–N–0155; FDA–2010–N–0601; FDA– 2023–N–2757] ACTION: Notice. The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. SUMMARY: FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796– 3794, PRAStaff@fda.hhs.gov. The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/ PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. SUPPLEMENTARY INFORMATION: Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB OMB control No. lotter on DSK11XQN23PROD with NOTICES1 Title of collection Premarket Notification Submission 510(k), Subpart E ............................................................................................ Good Manufacturing Practice Regulations for Type A Medicated Articles ............................................................. Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion ................................................................................................................................................................... Endorser Status and Actual Use in Direct-to-Consumer Television Ads ................................................................ Assessing Physiological, Neural and Self-Reported Response to Tobacco Education Messages ........................ Imports and Electronic Import Entries ..................................................................................................................... Current Good Manufacturing Practices for Blood and Related Regulations for and Blood Components; and Requirements for Donor Testing, Donor Notification, and ‘‘Lookback’’ ................................................................... Administrative Practices and Procedures; Formal Hearings ................................................................................... Adverse Experience/Events with Approved New Animal Drugs ............................................................................. Adverse Event Program for Medical Devices (Medical Product Safety Network (MedSun)) ................................. Human Cells, Tissues, and Cellular and Tissue-Based Products .......................................................................... New Animal Drugs for Minor Use and Minor Species ............................................................................................ Potential Tobacco Product Violations Reporting Form ........................................................................................... Food and Drug Administration Advisory Committee Regulations ........................................................................... Accreditation Scheme for Conformity Assessment Program .................................................................................. Quantitative Research on Front of Package Labeling on Packaged Foods ........................................................... Current Good Manufacturing Practice Regulations for Medicated Feed ................................................................ Medical Devices—Voluntary Improvement Program ............................................................................................... VerDate Sep<11>2014 17:49 Oct 10, 2023 Jkt 262001 PO 00000 Frm 00009 Fmt 4703 Sfmt 4703 E:\FR\FM\11OCN1.SGM 11OCN1 Date approval expires 0910–0120 0910–0154 7/31/2026 7/31/2026 0910–0917 0910–0918 0910–0919 0910–0046 7/31/2026 7/31/2026 7/31/2026 8/31/2026 0910–0116 0910–0191 0910–0284 0910–0471 0910–0543 0910–0605 0910–0716 0910–0833 0910–0889 0910–0920 0910–0152 0910–0922 8/31/2026 8/31/2026 8/31/2026 8/31/2026 8/31/2026 8/31/2026 8/31/2026 8/31/2026 8/31/2026 8/31/2026 9/30/2026 9/30/2026

Agencies

[Federal Register Volume 88, Number 195 (Wednesday, October 11, 2023)]
[Notices]
[Page 70422]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22490]



[[Page 70422]]

-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Formations of, Acquisitions by, and Mergers of Bank Holding 
Companies

    The companies listed in this notice have applied to the Board for 
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other 
applicable statutes and regulations to become a bank holding company 
and/or to acquire the assets or the ownership of, control of, or the 
power to vote shares of a bank or bank holding company and all of the 
banks and nonbanking companies owned by the bank holding company, 
including the companies listed below.
    The public portions of the applications listed below, as well as 
other related filings required by the Board, if any, are available for 
immediate inspection at the Federal Reserve Bank(s) indicated below and 
at the offices of the Board of Governors. This information may also be 
obtained on an expedited basis, upon request, by contacting the 
appropriate Federal Reserve Bank and from the Board's Freedom of 
Information Office at https://www.federalreserve.gov/foia/request.htm. 
Interested persons may express their views in writing on the standards 
enumerated in the BHC Act (12 U.S.C. 1842(c)).
    Comments regarding each of these applications must be received at 
the Reserve Bank indicated or the offices of the Board of Governors, 
Ann E. Misback, Secretary of the Board, 20th Street and Constitution 
Avenue NW, Washington, DC 20551-0001, not later than November 13, 2023.
    A. Federal Reserve Bank of Dallas (Karen Smith, Director, Mergers & 
Acquisitions) 2200 North Pearl Street, Dallas, Texas 75201-2272. 
Comments can also be sent electronically to 
[email protected]:
    1. Unifi Financial, Inc., San Antonio, Texas; to become a bank 
holding company by acquiring Stockmens National Bank in Cotulla, 
Cotulla, Texas.

    Board of Governors of the Federal Reserve System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023-22490 Filed 10-10-23; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.